Prevention of PONV With Traditional Chinese Medicine
Primary Purpose
Postoperative Nausea and Vomiting
Status
Recruiting
Phase
Not Applicable
Locations
China
Study Type
Interventional
Intervention
ST36 acupoint injection
Sponsored by
About this trial
This is an interventional prevention trial for Postoperative Nausea and Vomiting focused on measuring postoperative nausea and vomiting, bariatric surgery, Zusanli, anisodamine, obesity
Eligibility Criteria
Inclusion Criteria:
- Female patients with an American Society of Anesthesia (ASA) physical status I-IV
- Scheduled for elective bariatric surgery
- Written informed consent was obtained
Exclusion Criteria:
- Patients with contraindications for acupoint injection
- Difficulty in communicating with patients
- Allergic diathesis for drugs used in the study or serious illness (heart, lung, kidney, or liver, et. al)
- Coagulation dysfunction
- Pre-existing psychological or neurological disorder
- Pre-use medicine before surgery that would interferenced objective assessment (including the use of opioids, antiemetics or glucocorticoids)
- Gastroesophageal reflux disease
Sites / Locations
- The Second Hospital of Anhui Medical UniversityRecruiting
- The First Affiliated Hospital of Jinan University
- Henan Provincial People's Hospital
- Jiangsu Province Hospital
- The Affiliated Hospital of Xuzhou Medical University
- Beijing Chao-Yang Hospital, Capital Medical University
- Huashan Hospital Affiliated to Fudan University
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Placebo Comparator
Arm Label
ST36 acupoint injection group
pharmacoprophylaxis group
Arm Description
Patients in this group will received bilateral ST36 injection with scopolamine 1ml/point
Patients in this group will received bilateral ST36 acupoint injection with normal saline 1ml/point
Outcomes
Primary Outcome Measures
The incidence and severity of PONV
The incidence and severity of PONV after bariatric surgery
The incidence and severity of PONV
Total usage of rescue antiemetic drugs after bariatric surgery
The incidence and severity of PONV
The incidence and severity of PONV after bariatric surgery
The incidence and severity of PONV
The incidence and severity of PONV after bariatric surgery
The usage of rescue antiemetic drugs
Total usage of rescue antiemetic drugs after bariatric surgery
Secondary Outcome Measures
15-item Quality of Recovery(QoR-15)
QoR-15 will be used to evaluate recovery quality after anesthesia, including 15 items covering sleep, satisfaction, emotion and pain et. al,total score ranges from 0 to 150,the higher score means the higher quality of recovery.
Postoperative pain
Patients will be asked about their pain level at rest and moving on a numeric rating scale (0=no pain,10=worst pain imaginable) .
Consumption of analgesics
Cumulative analgesic consumption after surgery
Ambulation time
Interval time of patients' transit from bed rest to ambulation after surgery
Postoperative food and water intake time
Duration of eating and drinking after surgery
Postoperative hospitalization duration
Days of hospital staying after surgery
Pittsburgh sleep quality index
Pittsburgh sleep quality index will be used to evaluate quality of sleep. The higher score means the lower quality of sleep.
Gastrointestinal Symptom Rating Scale
Gastrointestinal symptom rating scale (GSRS) will be used to assess gastrointestinal function. The score ranges from 0 to 45. The higher score means poorer gastrointestinal function .
Hamilton depression rating scale
Hamilton depression scale (HAMD) will be used to assess depression. HAMD 24 item version score range 0-96. The higher score means the higher possibility of depression.
Hamilton anxiety rating scale
Hamilton anxiety scale (HAM-A) will be used to assess anxiety. Total score ranges from 0 to 56, the higher the score is, the more serious the anxiety is.
The MOS item short from health survey ,SF-36
Concise health status scale
Full Information
NCT ID
NCT05375721
First Posted
April 22, 2022
Last Updated
September 22, 2022
Sponsor
The Second Hospital of Anhui Medical University
Collaborators
The First Affiliated Hospital with Nanjing Medical University, Huashan Hospital, Henan Provincial People's Hospital, The Affiliated Hospital of Xuzhou Medical University, First Affiliated Hospital of Jinan University, Beijing Chao Yang Hospital
1. Study Identification
Unique Protocol Identification Number
NCT05375721
Brief Title
Prevention of PONV With Traditional Chinese Medicine
Official Title
ST36 Acupoint Injection With Anisodamine for Postoperative Nausea and Vomiting in Women Following Bariatric Surgery: A Multicentre, Randomised, Double-Blind Controlled Trial.
Study Type
Interventional
2. Study Status
Record Verification Date
September 2022
Overall Recruitment Status
Recruiting
Study Start Date
September 23, 2022 (Actual)
Primary Completion Date
February 1, 2024 (Anticipated)
Study Completion Date
May 1, 2024 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
The Second Hospital of Anhui Medical University
Collaborators
The First Affiliated Hospital with Nanjing Medical University, Huashan Hospital, Henan Provincial People's Hospital, The Affiliated Hospital of Xuzhou Medical University, First Affiliated Hospital of Jinan University, Beijing Chao Yang Hospital
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
5. Study Description
Brief Summary
Postoperative nausea and vomiting (PONV) is particularly one of the most common complications after laparoscopic sleeve gastrectomy (LSG). It can lead to serious adverse events and delayed activity, and prolong the time of rehabilitation and discharge. Numbers of studies have been focused on identifying risk factors and therapies of PONV. Unfortunately, there' no consistent comments for PONV prevention in women after LSG. Notably, Zusanli (ST36) acupoint and anisodamine have been evidenced to treat various gastrointestinal conditions. The primary outcome of this study was to evaluate the impact of anisodamine injection in ST36 on PONV in women following bariatric surgery.
Detailed Description
At the onset of this investigation, we have already identified several methodologic issues, such as the timing of the acupuncture intervention, sample size, perioperative anesthetic techniques, and appropriate control groups. All subjects were randomly assigned to the following two groups: ST36 acupoint injection group (bilateral ST36 acupoint injection with scopolamine); pharmacoprophylaxis group (bilateral ST36 injection with normal saline). The primary outcome of this study was the total incidence of PONV during the hospital and after the discharge. Participants were randomly assigned into different groups according to the computer-generated randomization sequence (http://www.randomization.com). Patients, surgeons, care givers, anesthesiologists, nursing staff, and outcomes assessor, were all blinded to the group assignment.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Postoperative Nausea and Vomiting
Keywords
postoperative nausea and vomiting, bariatric surgery, Zusanli, anisodamine, obesity
7. Study Design
Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
300 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
ST36 acupoint injection group
Arm Type
Experimental
Arm Description
Patients in this group will received bilateral ST36 injection with scopolamine 1ml/point
Arm Title
pharmacoprophylaxis group
Arm Type
Placebo Comparator
Arm Description
Patients in this group will received bilateral ST36 acupoint injection with normal saline 1ml/point
Intervention Type
Procedure
Intervention Name(s)
ST36 acupoint injection
Intervention Description
ST36 is located on the lateral surface of leg, 3 cun distal to the lower border of the patella, 1 finger-breadth lateral to the anterior crest of the tibia, between the tibialis anterior muscle and the tendon of the extensor digitorum longus. (The breadth of patient's middle finger was the proportional unit of measure "the cun", defined as the distance between the two medial ends of the creases of the interphalangeal joints when the patient's middle finger is flexed).
Primary Outcome Measure Information:
Title
The incidence and severity of PONV
Description
The incidence and severity of PONV after bariatric surgery
Time Frame
At 0-2 hours after surgery
Title
The incidence and severity of PONV
Description
Total usage of rescue antiemetic drugs after bariatric surgery
Time Frame
At 2-6 hours after surgery
Title
The incidence and severity of PONV
Description
The incidence and severity of PONV after bariatric surgery
Time Frame
At 6-12 hours after surgery
Title
The incidence and severity of PONV
Description
The incidence and severity of PONV after bariatric surgery
Time Frame
At 12-24 hours after surgery
Title
The usage of rescue antiemetic drugs
Description
Total usage of rescue antiemetic drugs after bariatric surgery
Time Frame
During 3 months after bariatric surgery
Secondary Outcome Measure Information:
Title
15-item Quality of Recovery(QoR-15)
Description
QoR-15 will be used to evaluate recovery quality after anesthesia, including 15 items covering sleep, satisfaction, emotion and pain et. al,total score ranges from 0 to 150,the higher score means the higher quality of recovery.
Time Frame
Postoperative 24 hours
Title
Postoperative pain
Description
Patients will be asked about their pain level at rest and moving on a numeric rating scale (0=no pain,10=worst pain imaginable) .
Time Frame
At 0-24 and 24-72 hours after surgery
Title
Consumption of analgesics
Description
Cumulative analgesic consumption after surgery
Time Frame
During 3 months after bariatric surgery
Title
Ambulation time
Description
Interval time of patients' transit from bed rest to ambulation after surgery
Time Frame
Postoperative 1-3 days
Title
Postoperative food and water intake time
Description
Duration of eating and drinking after surgery
Time Frame
Postoperative 1-3 days
Title
Postoperative hospitalization duration
Description
Days of hospital staying after surgery
Time Frame
2 weeks after surgery
Title
Pittsburgh sleep quality index
Description
Pittsburgh sleep quality index will be used to evaluate quality of sleep. The higher score means the lower quality of sleep.
Time Frame
Before surgery and at postoperative 3 months
Title
Gastrointestinal Symptom Rating Scale
Description
Gastrointestinal symptom rating scale (GSRS) will be used to assess gastrointestinal function. The score ranges from 0 to 45. The higher score means poorer gastrointestinal function .
Time Frame
Before surgery and at postoperative 3 months
Title
Hamilton depression rating scale
Description
Hamilton depression scale (HAMD) will be used to assess depression. HAMD 24 item version score range 0-96. The higher score means the higher possibility of depression.
Time Frame
Before surgery and at postoperative 3 months
Title
Hamilton anxiety rating scale
Description
Hamilton anxiety scale (HAM-A) will be used to assess anxiety. Total score ranges from 0 to 56, the higher the score is, the more serious the anxiety is.
Time Frame
Before surgery and at postoperative 3 months
Title
The MOS item short from health survey ,SF-36
Description
Concise health status scale
Time Frame
Before surgery and at the postoperative 3 months.The scale consists of 36 items,divided into 8 sections,score of each section ranges from 0 to 100, the higher the score is, the healthier is.
Other Pre-specified Outcome Measures:
Title
Consumption of propofol
Description
The total consumption of propofol during the surgery
Time Frame
During the bariatric surgery
Title
Consumption of remifentanil
Description
The total consumption of remifentanil during the surgery
Time Frame
During the surgery
Title
Consumption of sufentanil
Description
The total consumption of sufentanil during the surgery
Time Frame
During the surgery and postoperative 1-3 days
Title
Duration of anesthesia
Description
From beginning to the end of anesthesia
Time Frame
At the end of anesthesia
Title
Duration of surgery
Description
From beginning to the end of surgery
Time Frame
At the end of surgery
10. Eligibility
Sex
Female
Gender Based
Yes
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Female patients with an American Society of Anesthesia (ASA) physical status I-IV
Scheduled for elective bariatric surgery
Written informed consent was obtained
Exclusion Criteria:
Patients with contraindications for acupoint injection
Difficulty in communicating with patients
Allergic diathesis for drugs used in the study or serious illness (heart, lung, kidney, or liver, et. al)
Coagulation dysfunction
Pre-existing psychological or neurological disorder
Pre-use medicine before surgery that would interferenced objective assessment (including the use of opioids, antiemetics or glucocorticoids)
Gastroesophageal reflux disease
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Chunxia Huang, Ph.D
Phone
+8613500512159
Email
huangchunxia@ahmu.edu.cn
First Name & Middle Initial & Last Name or Official Title & Degree
Qi Xue, Ph.D
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Ye Zhang, M.D
Organizational Affiliation
The Second Hospital of Anhui Medical University
Official's Role
Principal Investigator
Facility Information:
Facility Name
The Second Hospital of Anhui Medical University
City
Hefei
State/Province
Anhui
ZIP/Postal Code
230601
Country
China
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Chunxia Huang, Ph.D
Phone
+8613500512159
Email
huangchunxia@ahmu.edu.cn
Facility Name
The First Affiliated Hospital of Jinan University
City
Guangzhou
State/Province
Guangdong
ZIP/Postal Code
510630
Country
China
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Zhiyong Dong, M.D
Facility Name
Henan Provincial People's Hospital
City
Zhengzhou
State/Province
Henan
ZIP/Postal Code
450003
Country
China
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Xu Wang
Facility Name
Jiangsu Province Hospital
City
Nanjing
State/Province
Jiangsu
ZIP/Postal Code
210029
Country
China
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Xuelong Zhou, M.D
Facility Name
The Affiliated Hospital of Xuzhou Medical University
City
Xuzhou
State/Province
Jiangsu
ZIP/Postal Code
221004
Country
China
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Guanglei Wang
Facility Name
Beijing Chao-Yang Hospital, Capital Medical University
City
Beijing
ZIP/Postal Code
100020
Country
China
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Rong Shi
Facility Name
Huashan Hospital Affiliated to Fudan University
City
Shanghai
ZIP/Postal Code
550001
Country
China
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Qiong Yu, M.D, Ph.D
First Name & Middle Initial & Last Name & Degree
Beibei Wang
12. IPD Sharing Statement
Plan to Share IPD
Yes
IPD Sharing Plan Description
All IPD that underlie results in a publication are to be shared with other researchers.
IPD Sharing Time Frame
The IPD will become available when summary data are published.
IPD Sharing Access Criteria
ChunXia Huang and Ye Zhang will review requests and criteria to share IPD. Requests are to be sent by email to huangchunxia@ahmu.edu.cn or zhangye_hassan@sina.com.
Learn more about this trial
Prevention of PONV With Traditional Chinese Medicine
We'll reach out to this number within 24 hrs